Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.64 |
| ▸ | SNCA | P37840 | 4/20 | 0.46 |
| ▸ | BCHE | P06276 | 8/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.38 |
| ▸ | FNTA | P49354 | 1/20 | 0.38 |
| ▸ | FNTB | P49356 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 1/20 | 0.35 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16612305 | 0.86 | MAPK1 (0.58) | MAPK1MEN1KMT2ATDP1L3MBTL1 | |
| SCHEMBL29557693 | 0.84 | MAPK1 (0.67) | MAPK1MEN1KMT2ATDP1L3MBTL1 | |
| SCHEMBL1208061 | 0.84 | MAPK1 (0.67) | MAPK1MEN1KMT2ATDP1L3MBTL1 | |
| SCHEMBL9567864 | 0.83 | MAPK1 (0.59) | MAPK1MEN1KMT2ATDP1L3MBTL1 | |
| SCHEMBL24860289 | 0.80 | MAPK1 (0.65) | MAPK1MEN1KMT2ATDP1L3MBTL1 | |
| SCHEMBL22778911 | 0.80 | MAPK1 (0.65) | MAPK1MEN1KMT2ATDP1L3MBTL1 | |
| SCHEMBL29378413 | 0.80 | MAPK1 (0.65) | MAPK1MEN1KMT2ATDP1L3MBTL1 | |
| SCHEMBL1828804 | 0.80 | SNCA (0.44) | MAPK1MEN1KMT2ATDP1L3MBTL1 | |
| SCHEMBL21752063 | 0.78 | SNCA (0.60) | MAPK1MEN1KMT2ATDP1L3MBTL1 | |
| SCHEMBL1926806 | 0.78 | NOX1 (0.69) | MAPK1MEN1KMT2ATDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3550030-B1 | METHOD FOR MEASURING GLYCATION RATE OF HEMOGLOBIN | TOYO BOSEKI (JP) | 2025-01-01 | — | — | EP | claimed |
| EP-3550030-A1 | METHOD FOR MEASURING GLYCATION RATE OF HEMOGLOBIN | TOYOBO CO., LTD. (JP) | 2019-10-09 | — | — | EP | claimed |
| US-7838304-B2 | Liquid reagent of color former and method of stabilizing the same | ARKRAY, INC. (JP) | 2010-11-23 | — | — | US | claimed |
| US-20090053823-A1 | Liquid Reagent of Color Former and Method of Stabilizing The Same | ARKRAY, INC. (JP) | 2009-02-26 | — | — | US | claimed |
| EP-1985670-A1 | LIQUID REAGENT OF COLOR FORMER AND METHOD OF STABILIZING THE SAME | Arkray, Inc. (JP) | 2008-10-29 | — | — | EP | claimed |
| EP-0926244-B1 | METHODS AND REAGENTS FOR QUANTITATIVELY DETERMINING ASCORBIC ACID | KYOWA MEDEX CO LTD (JP) | 2004-11-17 | — | — | EP | claimed |
| US-6153399-A | SIMPLE METHOD FOR QUANTITATIVE DETERMINATION IN SAMPLE BY REACTING IN AQUEOUS MEDIUM ASCORBIC ACID, OXYGEN, ASCORBATE OXIDASE, CHROMOGEN, AND PEROXIDASE; MEASURING ABSORBANCE; COMPARING WITH A CALIBRATION CURVE | KYOWA MEDEX CO., LTD. (JP) | 2000-11-28 | — | — | US | claimed |
| EP-0926244-A1 | METHODS AND REAGENTS FOR QUANTITATIVELY DETERMINING ASCORBIC ACID | KYOWA MEDEX CO., LTD. (JP) | 1999-06-30 | — | — | EP | claimed |
| US-12498366-B2 | Measurement method for fibroblast growth factor-23 by forming immunocomplexes | CANON MEDICAL DIAGNOSTICS CORPORATION (JP) | 2025-12-16 | — | — | US | disclosed |
| EP-3550030-B1 | METHOD FOR MEASURING GLYCATION RATE OF HEMOGLOBIN | TOYO BOSEKI (JP) | 2025-01-01 | — | — | EP | disclosed |
| US-12168795-B2 | Method for measuring cholesterol in low-density lipoprotein, measurement reagent, and measurement kit | HITACHI CHEMICAL DIAGNOSTICS SYSTEMS CO., LTD. (JP) | 2024-12-17 | — | — | US | disclosed |
| US-20240402163-A1 | Method for Measuring Fibroblast Growth Factor-23 and Reagent Therefor | HITACHI CHEMICAL DIAGNOSTICS SYSTEMS CO., LTD. (JP) | 2024-12-05 | — | — | US | disclosed |
| EP-3492600-B1 | METHOD FOR MEASURING GLYCATED HEMOGLOBIN | HITACHI CHEMICAL DIAGNOSTICS SYSTEMS CO LTD (JP) | 2024-04-24 | — | — | EP | disclosed |
| US-20230358767-A1 | METHOD FOR REDUCING MEASUREMENT ERROR | SEKISUI MEDICAL CO., LTD. (JP) | 2023-11-09 | — | — | US | disclosed |
| EP-0926244-B1 | METHODS AND REAGENTS FOR QUANTITATIVELY DETERMINING ASCORBIC ACID | KYOWA MEDEX CO LTD (JP) | 2004-11-17 | — | — | EP | disclosed |
| EP-1477811-A1 | INHIBITOR OF THE ADHESION OF METAL OXIDE-CONTAINING MATERIAL TO WASTE LIQUOR LINE OF AUTOMATIC ANALYZER | KYOWA MEDEX CO., LTD. (JP) | 2004-11-17 | — | — | EP | disclosed |
| US-6153399-A | SIMPLE METHOD FOR QUANTITATIVE DETERMINATION IN SAMPLE BY REACTING IN AQUEOUS MEDIUM ASCORBIC ACID, OXYGEN, ASCORBATE OXIDASE, CHROMOGEN, AND PEROXIDASE; MEASURING ABSORBANCE; COMPARING WITH A CALIBRATION CURVE | KYOWA MEDEX CO., LTD. (JP) | 2000-11-28 | — | — | US | disclosed |
| US-6153419-A | MIXING THE SAMPLE AND AN ENZYME HAVING ACTIVITY THAT IS INHIBITED BY 1,5-ANHYDROGLUCITOLIN A CONCENTRATION-DEPENDENT MANNER, AND MEASURING THE ACTIVITY OF THE ENZYME; DIAGNOSIS OF DIABETES | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2000-11-28 | — | — | US | disclosed |
| EP-0926244-A1 | METHODS AND REAGENTS FOR QUANTITATIVELY DETERMINING ASCORBIC ACID | KYOWA MEDEX CO., LTD. (JP) | 1999-06-30 | — | — | EP | disclosed |
| EP-0825258-A1 | METHOD FOR DETERMINING 1,5-ANHYDROGLUCITOL | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1998-02-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230358767-A1 | METHOD FOR REDUCING MEASUREMENT ERROR | CAT, MPO, UCHL1 | MAPK1 3822/4885MEN1 1789/4885KMT2A 1904/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.